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T. Qiao,* C. Liu and F. RanDepartment of Vascular Surgery, Drum Tower Hospital, Affiliated Hospital of Medical College,
Nanjing University, Nanjing 210008, ChinaObjective. To investigate the pathological and metabolic changes in the gastrocnemius muscle in patients with chronic vein
insufficiency (CVI).
Method. Thirty-six patients with varicose veins were investigated by ambulatory venous pressure (AVP) and duplex
ultrasonography. Twelve age and height-matched controls were used for comparison. Patients and controls consented to
participate in this study. Twenty-one patients with primary vein varicose (group AI) and 15 patients (group AII) with
primary deep venous valve incompetence (DVI) underwent biopsies of the gastrocnemius muscle during operation.
Adductor biopsies obtained from the same limbs served as a control group (group B) and specimens from controls subjects
without venous disease served as the second control group (group C). All the specimens were investigated by superoxide
dismutase (SOD), nitric oxide (NO), NaC–KC-ATPase, Ca2C-ATPase and lactic acid (LD) determinations. Samples were
subjected to light and electron microscopy following H & E staining, special ATPase, cytochrome oxidase/succinate
dehydrogenase (COX/SDH) stains.
Results. Normal muscle architecture was seen following H & E, ATPase and COX/SDH staining and normal cell
metabolism was observed in specimens of groups B and C. In group A, pathological changes were encountered in the
gastrocnemius muscle including disseminated myofibril atrophy, cell denaturation and necrosis, inflammatory cell
infiltration, proliferation and dilation of interfascicular veins. ATPase staining (pH 9.4) demonstrated grouping of atrophic
fibres, especially type I myofibril grouping, accompanied by moderate to severe atrophy of type II muscle fibres. However, no
patient had selective type I fibre atrophy. Enhanced enzymatic activity in single or multiple myofibrils was demonstrated by
COX/SDH staining in approximately half of the specimens in group AII. In group AII, electron microscopy showed
swelling, myelin figure denaturation of mitochondria, disruption of the myofibrils and increased lipid droplets in the
gastrocnemius muscle. Increased concentration of LD was found in most specimens from group A patients. There were also
reductions of SOD, NO, biochemical activity of NaC–KC-ATPase, Ca2C-ATPase with increasing concentration of LD in
these patients, most prominently in group AII. We found correlation between AVP assessments and the biochemical
measurements as well as morphological appearances of the gastrocnemius muscle.
Conclusion. Venous hypertension results in pathophysiological changes in the gastrocnemius muscles of patients with
DVI, associated with decreased calf pump function.Keywords: Gastrocnemius muscle; Chronic venous insufficiency; Pathophysiology; Calf muscle pump.Introduction
The factorswhich result in bloodflow from the leg to the
heart areheart pump function, competent venousvalves
and the calf muscle pump. The calf muscle pump is
considered to be ‘the second heart of body’.1 Restoration
of calf pump function is a problem often faced byng author. Dr Tong Qiao, MD, Department of Vascular
m Tower Hospital, Affiliated Hospital of Medical
jing University, Nanjing 210008, Jiangsu Province
: qiaotongmail@yahoo.com.cn
0430+ 07 $35.00/0 q 2005 Elsevier Ltd. All rights reservascular surgeons. Most published articles have con-
centrated on venous haemodynamics and restoring or
improving venous valve function. These techniques
have limited use in clinical practice. In general, the
morphological and metabolic changes in calf muscle
have been ignored in earlier research in this field. Some
patients continue to suffer symptoms (cramps in the leg,
tiredness, hot throbbing pain, swelling, eczema and
ulceration), which are not improved by surgical
treatment. The purpose of this pilot study was to
investigate the pathophysiological changes of calf
muscle in patients with chronic venous disease.Eur J Vasc Endovasc Surg 30, 430–436 (2005)
doi:10.1016/j.ejvs.2005.05.017, available online at http://www.sciencedirect.com onved.
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Forty-eight patients (including 12 control cases) gave
their consent to participation in this study. There were
26 men and 22 women, median age 44.5 years (range
26–65). In the venous disease cohort, the medical
history of venous disease ranged from 5 months to 20
years and the severity appeared to increase with time.
There were 22 patients of CEAP class 2 and 14 patients
of CEAP classes 4–6. Participating patients completed
a study questionnaire and where previous deep vein
thrombosis was suspected ascending venography was
performed before this research in order to exclude any
patient with post-thrombotic syndrome. The patients
with venous disease were mobile without evidence of
arterial insufficiency, which was excluded by Doppler
ankle pressure measurement. There was no limitation
of ankle movement on clinical examination. The
patients did not wear compression bandages or
stockings during the study period. Twelve age and
height-matched patients from the trauma or orthopae-
dics departments who had no clinical evidence of
venous disease comprised the control group. Normal
function of the arterial and venous system was
confirmed in all volunteers by duplex ultrasound
imaging. The control group also had full ankle
movement on clinical examination.
All patients with venous disease underwent biopsy
of the gastrocnemius muscle during their operation
(group A). Group A was divided into group AI (21
varicose veins patients) and group AII (15 DVI
patients). In these patients biopsies were also obtained
from thigh adductor muscle and served as a control
group (group B). A second control group comprised 12
biopsy specimens from gastrocnemius muscle of
patients without vascular disease from patients under-
going surgical treatment in the trauma and orthopae-
dics department (group C).
This study was approved by the medical committee
of hospital, and informed consent was obtained from
each patient.Examinations
Duplex ultrasound scan
The limbs were evaluated by duplex ultrasound
scanning using a SONOSITE 180 scanner (Sonosite,
USA), with 2.5–7.5 MHz probes. Patients stood for the
examinations and reflux was defined as retrograde
flow persisted for greater than 0.5 s following a
manual distal compression and release or Valsalvamanoeuvre.2,3 Sites examined included the common
femoral, femoral, popliteal, greater and small saphe-
nous veins.4,5 The venous disease patients were
classified into superficial venous disease (reflux in
the superficial veins with competent popliteal valves),
and deep venous incompetence (DVI) (popliteal reflux
on duplex examination) groups.Ambulatory venous pressure (AVP) measurement
All patients with venous disease patients and eight
volunteers in the control group agreed to undergo
AVP measurement. Venous pressure was measured by
inserting a needle into a vein on the dorsum of the foot.
The needle was connected through a pressure
transducer and an amplifier to a potentiometric pen
recorder and changes in venous pressure recorded
during rest and standard tiptoe exercise.6 The resting
pressure (P0) was measured in the standing position;
post-exercise pressure (PEP), the lowest pressure after
standard exercise, and 90% venous pressure refilling
time (RT90) were measured to assess the calf muscle
pump function with and without the effect of a
tourniquet placed below the knee.Pathophysiological examinations
Fresh muscle biopsies was divided into three samples,
avoided crushing when cutting the epimysium.
Samples were stored in K10 8C while clamped in an
isometric device to prevent contraction artefact and
were analysed for superoxide dismutase (SOD), nitric
oxide (NO), NaC–KC-ATPase, Ca2C-ATPase and
lactic acid (LD) within 6 h of collection according to
the instructions of the appropriate reagent kit (Jian-
cheng Medical Institute, China).
The second samples were immediately frozen at
K160 8C in isopentane cooled in liquid nitrogen.
Frozen sections were cut 6 mm in thickness in a
cryostat and stained with haematoxylin–eosin (H &
E), myofibrillar protein adenosine triphosphatase
(ATPase) at a pH of 9.4, cytochrome oxidase/succinate
dehydrogenase (COS/SDH) and were subjected to
light microscopy examination. The third group of
samples were examined by electron microscopy.Statistical analysis
Values are represented by the mean and SD. The
significance of differences in the parameters measured
in all samples was assessed by analysis of variance.
Differences were considered significant if P was less
than 0.05.Eur J Vasc Endovasc Surg Vol 30, October 2005
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Duplex ultrasound investigation demonstrated that
there were 21 patients with isolated superficial venous
disease of CEAP clinical class 2 and 15 patients with
deep venous incompetence, 14 of CEAP class 4–6, one
of CEAP class 2. Twelve controls from trauma and
orthopaedics department have not any superficial or
deep venous reflux.Fig. 1. (a) COX stain: normal muscle fibre from normal
gastrocnemius muscle of group C. Type I and type II muscleAVP measurement
The measurements of P0, PEP and RT90 in limbs of
each group were shown in Table 1. No significant
difference was found in the P0 between the three
groups. In limbs with DVI, PEP was higher than it in
control group (P!0.05). After application of a
tourniquet to occlude the superficial veins, the PEP
remained significantly higher in the DVI group than
both the control and PVV group. The venous refilling
time (RT90) was reduced in both the PVV and DVI
groups compared with the control group (P!0.05).
Application of a tourniquet returned the RT90 in PVV
group close to that in the control group. However, the
RT90 in the DVI group remained of short duration, as
would be expected.fibres are approximately equal in size and are polygonal in
configuration. The distribution of fibre types resembles that
of a checkerboard (40!). (b) Normal muscle from normal
gastrocnemius muscle of group C. Electron photomicro-
graph clearly shows the ultrastructure of skeletal muscle
(20,000!).Pathophysiological examinations
The biochemical changes in the all muscle biopsy
specimens are summarised in the Table 2. The
parameters of SOD, NO, biochemical activity of
NaC–KC-ATPase, CaC-ATPase in all muscle speci-
mens of groups B and C were in normal range. In the
specimens of 36 patients in A group, the concentration
of LD was raised compared to B and C group
specimens. In group AII, the concentrations of SOD
and NO in muscle cells were significantly reduced,
and biochemical activity of NaC–KC-ATPase, CaC-
ATPase was lower in than the control groups.
As are shown in Fig. 1(a) and (b), control biopsyTable 1. Ambulatory venous pressure values in each group (mean,
SD)
Control group
(nZ8)
PVV group
(nZ21)
DVI group
(nZ15)
P0 (kPa) 11.7 SD 1.4 12.3 SD 2.3 12.5 SD 3.3
PEP (kPa) 4.0 SD 0.6 5.7 SD 0.7 7.5 SD 1.4*
A 4.2 SD 0.8 4.1 SD 0.6 7.1 SD 1.6†
RT90 (s) 30.6 SD 8.0 17.7 SD 5.3* 10.6 SD 2.3†
A 32.6 SD 7.3 28.4 SD 6.8 14.2 SD 3.6†
A, with tourniquet.
* P!0.05 vs control group.
† P!0.05 vs control and PVV groups.
Eur J Vasc Endovasc Surg Vol 30, October 2005specimens removed from the B and C groups revealed
no significant pathological changes on H & E staining,
ATPase or COX/SDH and the ultrastructure of
myofibrils is clear and orderly under both light and
electron microscopy. In the gastrocnemius muscle of
patients with venous disease (group A) pathological
changes were found including disseminated myofibril
atrophy, cell denaturation and necrosis, inflammatory
cell infiltration, proliferation and dilation of inter-
fascicular veins. Examples are shown in Fig. 2(a)–(c).
Fig. 3(a) and (b) shows that in 13 of 15 specimens in
group AII and five of 21 specimens in group AI,
ATPase stain (pH 9.4) demonstrated grouping of
myofibrils, especially for type I myofibrils,
accompanied by moderate to severe atrophy of type
II myofibrils. At a pH of 9.4, type I fibres were pale in
ATPase staining and type II fibres exhibit darkly
staining. We did not find any specimens with selective
type I fibre atrophy. Fig. 3(c) shows enhanced
enzymatic activity in single or multiple myofibrils
with the COX/SDH stain which was found in eight of
Table 2. Results of biochemical analysis of muscle in the different clinical groups (mean, SD)
Group NaC–KC-ATPase
(mmol/mg pro)
Ca2C-ATPase
(mmol/mg pro)
LD (mmol/g pro) NO (mmol/g pro) SOD (U/mg pro)
AI 1.03 SD 0.22 0.67 SD 0.13 1004 SD 312* 25 SD 2.4 74 SD 15
AII 0.49 SD 0.14† 0.45 SD 0.11† 1225 SD 372* 18 SD 2.2† 43 SD 9.9†
B 1.11 SD 0.31 0.96 SD 0.25 615 SD 15432 32 SD 3.2 70 SD 21
C 1.08 SD 0.29 0.81 SD 0.16 567 SD 127 28 SD 3.0 88 SD 17
AI, gastrocnemius muscle, PVV group; AII, gastrocnemius muscle, DVI group; B adductor muscle, PVV and DVI groups; C gastrocnemius
muscle, control patients.
* P!0.05 vs B, C group.
† P!0.01 vs AI, B, C group.
Fig. 2. (a) Gastrocnemius muscle from a group A (venous
disease) patient, H & E stain: a single myofibril shows
atrophy and lymphocyte infiltration (200!). (b) Gastro-
cnemius muscle from a group A (venous disease) patient, H
& E stain: multiple myofibril atrophy (400!). (c) Gastro-
cnemius muscle from a group A (venous disease) patient H
& E stain: dilation of interfascicular vein (200!).
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swelling, myelin figure denaturation of mitochondria,
disruption of the myofibrils and increased lipid
droplets in gastrocnemius were apparent in 10 of 15
specimens in group AII and three of 21 specimens in
group AI. (Fig. 4(a)–(c)).Discussion
The efficiency of calf muscle pump relies on normally
functioning venous valves, powerful contraction of
calf muscle, full ankle joint movement and normal
muscular fasciae. Any malfunction in this system may
contribute to calf pump dysfunction, influencing the
venous haemodynamics and resulting in venous
hypertension.7 Patients with chronic venous disease
have venous reflux, weakness of calf muscle strength
and calf pump dysfunction.8 The aim of this study was
to investigate the relationship of venous reflux and
pathophysiological muscle changes.
In normal human skeletal muscle, type I and type II
muscle fibres are approximately equal in size and are
polygonal rather than angular in configuration. The
distribution of fibre types resembles that of a checker-
board, with light and dark fibres arranged in an evenly
mixed mosaic pattern.9 We found changes character-
ised by denervation and reinnervation in gastrocne-
mius muscle from patients with venous disease, but in
no other biopsy specimens. Electron microscopy
showed denaturation of mitochondria and disruption
of the myofibrils in the AII group. In muscle cells
mitochondria are scattered among and around the
myofibrils and provide the ATP needed to power
muscular contractions. We suspected that the ATP
demands of a contracting skeletal muscle might not be
met by the impaired mitochondria in patients with
CVI.
NaC–KC-ATPase, found in plasma membranes of
most animal cells, catalyses ATP-dependent transport
of NaC out of a cell in exchange for KC entering the
muscle cell. Ca2C-ATPases, in endoplasmic reticulum
(ER) and plasma membranes of muscle cells, catalysesEur J Vasc Endovasc Surg Vol 30, October 2005
Fig. 3. (a) Gastrocnemius muscle from a group AII (DVI),
ATPase stain: type I myofribrils grouping (200!). (b)
Gastrocnemius muscle from a group AII (DVI), ATPase
stain: type I myofibrils grouping, accompanied by moderate
to severe atrophy of type II myofibrils (200!). (c)
Gastrocnemius muscle from a group AII (DVI), COX/SDH
stain: enhanced enzymatic activity in single or multiple
myofibrils (100!).
Fig. 4. (a) Gastrocnemius muscle from a group AII (DVI).
Electron microscopy shows swelling, disruption of the
myofibrils and mitochondrial denaturation (20,000!). (b)
Electron microscopy of gastrocnemius muscle from group
AII (DVI) showing increased lipid droplets in myofibrils
(30,000!). (c) Electron microscopy of gastrocnemius muscle
from group AII (DVI) showing myelin figure denaturation of
mitochondria (30,000!).
T. Qiao et al.434ATP-dependent transport of Ca2C away from the
cytosol, either into the ER lumen or out of the cell. We
found reduced ATPase activity in group AII speci-
mens. This might lead to impaired ability to maintain
or restore NaC and KC balance across the sarcolemma
during repeated muscle contractions. An abnormal
intracellular Ca2C concentration would result in
defective muscle function, impacting the muscle
excitation-contraction coupling (E–C-C), causing pro-
longed physiological Ca2C-elevation, slowing ofEur J Vasc Endovasc Surg Vol 30, October 2005relaxation, leading to mitochondrial damage and
disorganisation of myofibrils and muscle weakness.10
This might be the cause of calf muscle fatigue in CVI
patients. It has been shown that failure of Ca2C release
is strongly implicated in muscle fatigue, depressed
NaC–KC-ATPase enzyme activity of up to 17% has
been reported during fatigue, while training studies
The Impact of Gastrocnemius Muscle Cell Changes in Chronic Venous Insufficiency 435have shown between 13 and 16% increase in NaC–KC-
ATPase activity.11–14
Superoxide dismutase is one of the most important
and powerful antioxidants in tissue. Contractions of
skeletal muscles produce an increased concentration
of superoxide anions and activity of hydroxyl radicals
in the extracellular space which alters the skeletal
muscle oxidative capacity.15 Some studies indicated
that superoxide radicals play an important role in the
pathogenesis of varicose veins, and SOD can inhibit
the expression of free radicals and the adhesion
molecules, protecting skeletal muscle from impair-
ment.16,17 We found that biopsies from the AII group
had low levels of muscle SOD compared to the other
groups. It has been demonstrated that interval and
continuous exercise training results in increases in
SOD activity and recovery time after exercise was
shortened if Vitamin C, E or exogenous SOD was
supplied.18,19 It may be possible to this type of
treatment in patients with venous disease in order to
improve calf muscle pump function.
Concentration of lactic acid in blood (LAB) is one of
the main measures used to evaluate skeletal muscle
fatigue in sports medicine and it is mainly influenced
by the balance between production and elimination of
lactic acid in skeletal muscle (LAM).20 The concen-
tration of LAM directly evaluates lactic acid metab-
olism in muscle.21 We measured the concentration of
LAM to estimate the metabolism of gastrocnemius
cells and found that the concentration of LAM in A
group including PVV and DVI patients was increased
compared to control specimens. This would lower the
intracellular pH and alter functional characteristics of
key enzymes in muscle cells. Lactic acid diffuses out of
the muscle fibers and enters the Cori cycle in which
lactic acid is metabolised in the liver returning glucose
to the muscle cells during recovery,22 Until LAM levels
fall premature muscle fatigue may be the result.
A review of the literature suggests that the effects of
nitric oxide (NO) on skeletal muscles fibres can be
classified in direct effects and cGMP-mediated effects.
These include NO-stimulated glucose uptake, glycoly-
sis and mitochondrial respiration, increasing the
shortening velocity of loaded or unloaded contrac-
tions. NO has a clear role in regulating basal vascular
tone at rest and contributing in part to the blood flow
in recovery after exhaustive exercise.23–26 The data
from our study shows that the concentration of NO in
biopsies from the CVI group was lower than in the
control group.
Impaired biochemical function and morphological
have also been reported in samples of skeletal muscle
from patients with arterial occlusive disease or disuse
atrophy.27–29 Ischaemia affects each muscle fibre typein different ways according to its particular metabolic
and functional properties. In some studies effects on
type I fibres predominated and other studies indicated
a selective vulnerability of the fast glycolytic fibres.30,31
Studied by Clyne et al. showed decreased levels of
aerobic enzymes paralleling decreased Doppler ankle
pressure, while claudicants demonstrated increased
levels of anaerobic enzymes.32 We consider that anoxia
due to arterial ischaemia or venous congestion would
both lead to skeletal muscle impairment characterised
by denervation and reinnervation.
We used AVP measurement for quantitative exam-
ination of the peripheral venous haemodynamics since
venous hypertension is the main factor predisposing
to venous insufficiency.7,8,33 In our series PEP was
elevated in patients with a venous disease, with the
more severely affected patients having the highest
PEP, in keeping with published literature.34 A shorter
RT90 and higher PEP resulted in persistent venous
hypertension in limbs with DVI. Patients with the
highest PEP also had the greatest disturbance in
biochemical measurements and morphological
changes in their biopsies. These findings provide
further evidence of the interplay between the meta-
bolic and haemodynamic factors that might contribute
to the calf pump dysfunction in patients with DVI.
In this study, we classified the clinical presentation
of our patients according to the CEAP method.35 Our
patients with the highest CEAP grades has the greatest
haemodynamic changes as well as the most severe
biochemical and histological changes in their muscle
biopsies. Correlation with the CEAP clinical grade
confirms that our findings are related to an inter-
nationally agreed measure of disease severity.
In conclusion, we have found structural and
metabolic abnormalities in the skeletal muscle cells
of the calf in patients with venous insufficiency which
are most prominent in the most severely affected
patients. Some of the symptoms reported by patients
in their lower limbs may be attributable to these
changes. It has been suggested that pharmacological
intervention may be useful in addressing similar
muscle changes reported in patients with peripheral
arterial diseases.36–38 In the future we might add to
conventional management of venous disease by
including physical therapy or therapeutic exercise,
muscle nutrition and antioxidant therapy. Clearly
these proposals would have to be investigated in
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